Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital
– Retiring $17.5 million in Avenue Capital debt and entering into a $11.5 million loan agreement with an insider-led investor...
Cancer
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
– Financing strengthens balance sheet and is expected to provide sufficient cash runway through June 2026 – – Retiring $17.5...
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark...
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines
New patent expected to provide market exclusivity into 2036 Zembrace® SymTouch® (sumatriptan succinate injection) 10mg is indicated for the acute...
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval follows EU approval of Dupixent for...
Defence’s Corporate Updates, Arranges Financing
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Latest innovations in RayStation, RayCare, and RayIntelligence to be presented at ASTRO 2024
STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- RaySearch will be exhibiting its latest software innovations at ASTRO in Washington, D.C., September...
Brain Cancer Support and Solutions Alliance Launches Dedicated Nurse Navigator for Comprehensive Patient and Caregiver Assistance
KANSAS CITY, Mo. and HEWLETT, N.Y. and PALO ALTO, Calif., Sept. 26, 2024 /PRNewswire/ -- The Brain Cancer Support and Solutions...
ISS National Lab Sponsoring Botanical, Cardiac, and Genetic Research During Five-Month Science Mission to Orbiting Outpost
During NASA's SpaceX Crew-9 mission to the space station, the crew will support dozens of projects sponsored by the ISS...
WebMD Announces 2024 Health Heroes: Visionaries Leveraging AI in Medicine
NEWARK, N.J., Sept. 26, 2024 /PRNewswire/ -- WebMD today announced the recipients of the 2024 WebMD Health Hero Awards, recognizing...
RICOH 3D for Healthcare and Kallisio partner to enhance radiation oncology care with Stentra™ oral stent
EXTON, Pa., Sept. 26, 2024 /PRNewswire/ -- Ricoh USA, Inc. and Kallisio today announced a strategic partnership to manufacture and distribute...
Jaguar Health Scientific Advisory Board Member to Share Poster Presentation at American Society of Clinical Oncology (ASCO) Quality Care Symposium About the Methodologies Involved in Designing an Advocate-Led Quality of Life Survey for Cancer Patients and Survivors
Jaguar's commercial focus on cancer supportive care aims to use the best tools and techniques that assess the quality of...
Reveal MRI Launches the Reveal Total Scan: A Breakthrough in Preventative Health Screening
HENDERSON, NV / ACCESSWIRE / September 26, 2024 / In early 2024, Reveal MRI (www.revealmri.com) introduced an innovative full-body MRI...
Sunshine Biopharma Launches Two New Generic Prescription Drugs
FORT LAUDERDALE, FL / ACCESSWIRE / September 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering...
International Myeloma Foundation to Hold First Latin American Myeloma Network Summit in Brazil on September 28
The inaugural IMF Latin American Myeloma Network Summit will take place on Saturday, September 28, after the International Myeloma Society...
Fortress Biotech to Participate in October 2024 Investor Conferences
MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring...
Interim results for the six months ended June 30, 2024
September 26, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2024...
Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids
Revolutionizing Fibroid Treatment with Enhanced Precision, Control & FlexibilityREDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a...
Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence
The CD19/CD70 Dual CAR is Specifically Designed to Address Both the B-cell and T-cell Dysfunction Implicated in Autoimmune DiseasesALLO-329, is...
INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort
BOCA RATON, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and...